Morgan Stanley Reiterates Buy Rating for UnitedHealth Group
Morgan Stanley maintains its buy rating on UnitedHealth Group, setting a $468 price target, a 12.60% upside from the current price.
Key Points
- Morgan Stanley reiterated its buy rating for UnitedHealth Group with a price target of $468 on June 30, 2026.
- Morgan Stanley's $468 price target implies 12.60% upside from UnitedHealth Group Incorporated's ($UNH) current $415.63 share price.
- Shares of NYSE:UNH traded at $419.82 on Tuesday, with a market cap of $388.6 billion and a P/E ratio of 32.3.
- Insiders at UnitedHealth Group, including CEO Stephen Hemsley, recently bought shares, and multiple analysts maintain a buy rating.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Morgan Stanley has reiterated its buy rating on UnitedHealth Group Incorporated (NYSE:UNH) with a price target of $468. This affirmation came on June 30, 2026, as Erin Wright from Morgan Stanley maintained confidence in the healthcare giant's performance.
Morgan Stanley vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in UnitedHealth Group
BlackRock, Inc. reduced its holdings in UnitedHealth Group by 1,276,021 shares, bringing its total to 73,467,531 shares valued at about $19.88 billion. Meanwhile, Vanguard Capital Management LLC opened a new position with 58,870,777 shares worth approximately $15.93 billion. State Street Corp added 100,016 shares, ending with 45,332,186 shares valued at around $12.27 billion. Capital World Investors increased its stake by 5,192,373 shares to 27,783,415 shares, valued at roughly $7.52 billion. Geode Capital Management, LLC added 977,105 shares, reaching a total of 22,768,695 shares worth about $6.14 billion.
UnitedHealth Group Incorporated Stock Up 5.8%
Shares of NYSE:UNH traded near $419.82 on Tuesday. UnitedHealth Group has a market cap of approximately $388.6 billion, a P/E ratio of 32.3, and a beta of 0.65, indicating lower volatility compared to the market. The stock's 52-week range is between $234.60 and $427.93, with a 50-day moving average of $382.92 and a 200-day moving average of $335.87.
$UNH price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
UnitedHealth Group reported revenue of about $449.71 billion, with a modest growth rate of 2%. The company achieved an EPS of $13.26, a net margin of 2.68%, and a return on equity of 12.18%. Investors can look forward to the next earnings release on July 16, 2026.
Dividend
UnitedHealth Group offers an annual dividend rate of $9.28, yielding 2.17%. The company's dividend payout ratio stands at 66.57%, reflecting a commitment to returning value to shareholders.
Insider Buying and Selling at UnitedHealth Group Incorporated
On June 23, 2026, several insiders, including CEO Stephen Hemsley, purchased shares of UnitedHealth Group. Hemsley acquired 46 shares, while other executives like EVP & Chief Legal Officer Christopher Zaetta bought 61 shares. These transactions were not part of any pre-planned trading programs.
Analysts Set New Price Targets
On June 30, 2026, Morgan Stanley maintained its buy rating on UnitedHealth Group with a $468 price target. B of A Securities also maintained a buy rating with a target of $475 on June 24, 2026. Meanwhile, on June 17, 2026, Leerink Partners reiterated a buy rating, setting a target of $462. The consensus among 26 analysts is a buy recommendation, with an average target price of $411.31.
About UnitedHealth Group
UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through segments such as Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, offering a wide range of health services. The company provides care delivery, pharmacy care services, software solutions, and consumer-oriented health benefit plans. Founded in 1974, UnitedHealth Group serves clients both in the United States and internationally, employing around 390,000 people.
Bottom Line
Morgan Stanley's reiterated buy rating and $468 price target reflect confidence in UnitedHealth Group's prospects. The company's substantial market cap and consistent earnings growth make it a key player in the healthcare sector. As insiders continue to buy shares and analysts maintain positive ratings, investors will be watching closely for the upcoming earnings report.
Get UnitedHealth Group Incorporated alerts
New 13F filings, insider trades, and analyst moves on $UNH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.